Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New biotechnology companies flock to London’s first bioscience innovation centre

08.02.2007
Two new companies have opted to join the London Bioscience Innovation Centre (LBIC), which is the first centre of its kind in London.

LBIC currently provides 21st century laboratory and office facilities for more than 23 biotechnology and diagnostic companies, life science product and service providers, venture investors and small pharmaceutical companies. The two new clients that have recently moved to LBIC are Bridge Genoma and Domainex.

‘LBIC’s emphasis on quality makes us stand out from the crowd and an atmosphere of collegiality underpins everything we do,’ said Professor Colin Howard Vice-Principal, for the Royal Veterinary College and CEO, The London Bioscience Innovation Centre. ‘We are keen to ensure that new client companies are a good ‘fit’ with the philosophy of LBIC, whether they are biotechnology companies, or associated service organisations.’

Bridge Genoma is a private genetic testing lab specialising in Preimplantation Genetic Diagnosis (PGD). Using the latest technology any known genetic defect can be identified by ‘fingerprinting’ that region of the DNA which may carry the mutation causing the disease. More than 10,000 conditions are known and include such diseases as Cystic Fibrosis, Spinal Muscular Atrophy, Huntingdon disease, Batten disease, Haemophilia A and Sickle Cell Disease.

... more about:
»Biotechnology »Bridge »Domainex »Genoma »LBIC

By Bridge Genoma co-operating with other clinics patients can have this resource made available to them regardless of where they live in the UK. The IVF treatment can take place at a clinic anywhere in the UK and the cell can be sent down for testing – without the parent needing to travel. Currently around half a dozen clinics work with Bridge Genoma from all around the UK including Liverpool, Oxford and London.

‘Until now clinics have had to send samples abroad, which isn’t ideal when you only have a one or two day window at most to carry out the tests.’ Said Professor Alan Handyside, Director, Bridge Genoma. ‘LBIC also offered us good security, health and safety provision, and great facilities. As well as being a great place to network with other scientists, LBIC also offers us facilities that are impressive to our peers and clients.’

Domainex are a spin-out company from The Institute of Cancer Research, Birkbeck , and University College that first set up in 2002. Domainex has created a system that allows the structure of difficult proteins, to be unlocked this is an essential part needed in the process of developing new drugs. Domainex’s system means that pharmaceutical companies can work much faster in drug research and address novel medical targets.

Domainex moved to LBIC in November 2006 and is anticipating further growth in business now that it is based there. Domainex list one of LBIC’s primary benefits is its central location.

Keith Powell, CEO of Domainex, said, ‘The very flexible facilities and availability of meeting rooms for client visits are enormously helpful to young companies which seek to minimize overhead and focus resources on the development of the business. Moving out of the academic environment is an essential part of a growing spin-out, we see the LBIC relationship as a partnership where both sides gain’.

For more information contact: Becci Cussens, Communications Management, Tel: 01727 737980, becci@communicationsmanagement.co.uk

Becci Cussens | alfa
Further information:
http://www.lbic.com/

Further reports about: Biotechnology Bridge Domainex Genoma LBIC

More articles from Life Sciences:

nachricht Mass spectrometry sheds new light on thallium poisoning cold case
14.12.2018 | University of Maryland

nachricht Protein involved in nematode stress response identified
14.12.2018 | University of Illinois College of Agricultural, Consumer and Environmental Sciences

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Data use draining your battery? Tiny device to speed up memory while also saving power

14.12.2018 | Power and Electrical Engineering

Tangled magnetic fields power cosmic particle accelerators

14.12.2018 | Physics and Astronomy

In search of missing worlds, Hubble finds a fast evaporating exoplanet

14.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>